2-[(4-Bromophenyl)sulfanyl]-6-(3,4-dichlorophenyl)pyridine-3-carbonitrile

Catalog No. :
ACQFGE764
CAS No. :
252059-66-8
Molecular Formula :
C18H9BrCl2N2S
Molecular Weight :
436.16

IUPAC Name:2-((4-bromophenyl)thio)-6-(3,4-dichlorophenyl)nicotinonitrile

2-[(4-Bromophenyl)sulfanyl]-6-(3,4-dichlorophenyl)pyridine-3-carbonitrile structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g90%$323.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-[(4-Bromophenyl)sulfanyl]-6-(3,4-dichlorophenyl)pyridine-3-carbonitrile
IUPAC Name2-((4-bromophenyl)thio)-6-(3,4-dichlorophenyl)nicotinonitrile
MDL No.MFCD00215062
Molecular FormulaC18H9BrCl2N2S
Molecular Weight436.16
SMILESN#CC1=CC=C(C2=CC=C(Cl)C(Cl)=C2)N=C1SC3=CC=C(Br)C=C3
InChI KeyYINCKGVZGZNBRC-UHFFFAOYSA-N
Synonym2-[(4-BROMOPHENYL)SULFANYL]-6-(3,4-DICHLOROPHENYL)NICOTINONITRILE;2-[(4-bromophenyl)sulfanyl]-6-(3,4-dichlorophenyl)pyridine-3-carbonitrile;3-Pyridinecarbonitrile, 2-[(4-bromophenyl)thio]-6-(3,4-dichlorophenyl)-
CAS No.252059-66-8

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACQFGE764 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACQFGE764 route product structure diagram
    ACQFGE764252059-66-8
Inquiry

2. ACQFGE764 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACQFGE764 route product structure diagram
    ACQFGE764252059-66-8
Inquiry

Comments (0)